ARID1A and intrahepatic cholangiocarcinoma: A study (28) developed in Italy revealed that ARID1A variation was recorded in 18.2% and indicated that ARID1A variations are an independent predictor of poor prognosis in ICC (OR = 6.9, 95% CI: 2.3–21.0, P = 0.0007).